BIOCHEMICAL EVALUATION OF ANTIDIABETIC PROPERTIES OF SWERTIAMARIN, A SECOIRIDOID GLYCOSIDE OF ENICOSTEMMA LITTORALE LEAVES, STUDIED IN HIGH-FAT DIET–FED LOW-DOSE STREPTOZOTOCIN-INDUCED TYPE 2 DIABETIC RATS
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i10.28152Keywords:
Swertiamarin, High-fat diet, Streptozotocin, Antidiabetic propertyAbstract
Objective: Swertiamarin, a secoiridoid glycoside present in the leaves of Enicostemma littorale, is reported to be responsible for its pharmacological and beneficial properties. The present study was aimed to biochemically evaluate the antidiabetic properties of Swertiamarin in high fat diet fed - low dose streptozotocin (STZ)-treated diabetic rats.
Methods: High-fat diet-fed low-dose STZ was used to induce experimental type 2 diabetes in rats. Diabetic rats were orally treated with swertiamarin (50 mg/kg b.w./rat/day) for 30 days. The physiological criterions such as food and fluid intake were recorded. Oral glucose tolerance test was performed. The levels of fasting blood glucose, plasma insulin, glycosylated hemoglobin A1c (HbA1c), hemoglobin, and homeostasis model assessment of insulin resistance (HOMA-IR) values were estimated. The activities of key enzymes involved in carbohydrate and glycogen metabolism in the liver and kidney tissues were assayed. The glycogen content in liver tissue was estimated.
Result: Oral administration of swertiamarin to diabetic rats established a significant decline in the levels of fasting blood glucose, HbA1c as well as HOMA-IR values and an increase in plasma insulin and hemoglobin levels. The altered activities of key enzymes of carbohydrate and glycogen metabolism in liver and kidney tissues of diabetic rats were restored to near normalcy by swertiamarin treatment.
Conclusion: Swertiamarin treatment maintains normoglycemia in diabetic rats by modulating the activities of key carbohydrate and glycogen metabolizing enzymes in the hepatic and renal tissues.
Downloads
References
Arafat M, Salam A, Arafat O. The association of Type 2 diabetes with obesity and other factors: In multinational community. Int J Pharm Pharm Sci 2014;6:257-60.
Edgerton DS, Kraft G, Smith M, Farmer B, Williams PE, Coate KC, et al. Insulin’s direct hepatic effect explains the inhibition of glucose production caused by insulin secretion. JCI Insight 2017;2:e91863.
Prentki M, Nolan CJ. Islet β cell failure in Type 2 diabetes. J Clin Invest 2006;116:1802-12.
Radziuk J, Pye S. Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis. Diabetes Metab Res Rev 2001;17:250 72.
Nuttall FQ, Ngo A, Gannon MC. Regulation of hepatic glucose production and the role of gluconeogenesis in humans: Is the rate of gluconeogenesis constant? Diabetes Metab Res Rev 2008;24:438-58.
Kalsi A, Singh S, Taneja N, Kukal S, Mani S. Current treatments for Type 2 diabetes, their side effects and possible complementary treatments. Int J Pharm Pharm Sci 2015;7:13-8.
Gite VN, Pokharkar RD, Chopade VV, Takate SB. Hepatoprotective activity of Enicostemma axillare in paracetamol induced hepatotoxicity in albino rats. Int J Phar Life Sci 2010;1:50-3.
Jaishree V, Badami S, Krishnamurthy PT. Antioxidant effect and hepatoprotective effect of ethyl acetate extract of Enicostemma axillare (Lam) Raynal against CCl4 induced liver injury in rats. Ind J Exp Bio 2010;48:896-904.
Leelaprakash G, Dass S. In-vitro anti-inflammatory activity of methanol extract of Enicostemma axillare. Int J Drug Dev Res 2011;3:189-96.
Li HL, Peng XJ, He JC, Feng EF, Xu GL, Rao GX, et al. Development and validation of a LC-ESI-MS/MS method for the determination of swertiamarin in rat plasma and its application in pharmacokinetics. J Chromatogr B Analyt Technol Biomed Life Sci 2011;879:1653-8.
Vaidya H, Rajani M, Sudarsanam V, Padh H, Goyal R. Antihyperlipidaemic activity of swertiamarin, a secoiridoid glycoside in poloxamer-407-induced hyperlipidaemic rats. J Nat Med 2009;63:437 42.
Vaidya H, Prajapati A, Rajani M, Sudarsanam V, Padh H, Goyal RK, et al. Beneficial effects of swertiamarin on dyslipidaemia in streptozotocin-induced Type 2 diabetic rats. Phytother Res 2012;26:1259-61.
Selvam R, Muruganantham K, Subramanian S. Phytochemical screening and evaluation of in vitro antioxidant efficacy of Enicostemma littorale Blume leaves extract. Int J Pharm Sci Rev Res 2018;49:113-20.
Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for Type 2 diabetes and pharmacological screening. Pharmacol Res 2005;52:313-20.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
Trinder P. Determination of blood glucose using an oxidase peroxidase system with a non-carcinogenic chromogen. J Clin Pathol 1969;22:158 61.
Drabkin DL, Austin JH. Spectrophotometric constants for common hemoglobin derivatives in human, dog and rabbit blood. J Biol Chem 1932;98:719-33.
Nayak SS, Pattabiraman TN. A new colorimetric method for the estimation of glycosylated hemoglobin. Clin Chim Acta 1981;109:267 74.
Brandstrup N, Kirk JE, Bruni C. The hexokinase and phosphoglucoisomerase activities of aortic and pulmonary artery tissue in individuals of various ages. J Gerontol 1957;12:166-71.
Pogson CI, Denton RM. Effect of alloxan diabetes, starvation and refeeding on glycolytic kinase activities in rat epididymal adipose tissue. Nature 1967;216:156-7.
King J. Colorimetric determination of serum lactate dehydrogenase. J Med Lab Tech 1959;16:265-9.
Koide H, Oda T. Pathological occurrence of glucose-6-phosphatase in serum in liver diseases. Clin Chim Acta 1959;4:554-61.
Gancedo JM, Gancedo C. Fructose-1, 6-bisphosphatase, phosphofructo kinase and glucose-6-phosphate dehydrogenase from fermenting and non-fermenting yeasts. Arch Mikrobiol 1971;76:132-8.
Ells HA, Kirkman HN. A colorimetric method for assay of erythrocytic glucose-6-phosphate dehydrogenase. Proc Soc Exp Biol Med 1961;106:607-9.
Leloir LF, Goldemberg SH. Glycogen synthetase from rat liver: (Glucose)n + (UDPG)→(Glucose)n+1 +UDP. In: Colowick SP, Kalpan NO, editors. Methods in Enzymology. New York: Academic Press; 1962. p. 145-7.
Cornblath M, Randle PJ, Parmeggiani A, Morgan HE. Effects of phospholipids and anoxia on lactate production, glycogen content, and phosphorylase activity in the perfused isolated rat heart. J Biol Chem 1963;238:1592-97.
Morales MA, Jabbagy AJ, Terenizi HR. Mutations affecting accumulation of Neurospora glycogen. News lett 1973;20:24-5.
Malireddy S, Kotha SR, Secor JD, Gurney TO, Abbott JL, Maulik G, et al. Phytochemical antioxidants modulate mammalian cellular Epigenome: Implications in health and disease. Antioxid Redox Signal 2012;17:327-39.
Ghibaudi L, Cook J, Farley C, Van Heek M, Hwa JJ. Fat intake affects adiposity, morbidity factors, and energy metabolism of Sprague-Dawley rats. Obes Res 2002;10:956-63.
Ikemoto S, Takahashi M, Tsunoda N, Maruyama K, Itakura H, Ezaki O, et al. High-fat diet-induced hyperglycemia and obesity in mice: Differential effects of dietary oils. Metabolism 1996;45:1539-46.
Wang H, Storlien LH, Huang XF. Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and agRP mRNA expression. Am J Physiol Endocrinol Metab 2002;282:E1352-9.
Buettner R, Parhofer KG, Woenckhaus M, Wrede CE, Kunz-Schughart LA, Schölmerich J, et al. Defining high-fat-diet rat models: Metabolic and molecular effects of different fat types. J Mol Endocrinol 2006;36:485-501.
Mythili MD, Vyas R, Akila G, Gunasekaran S. Effect of streptozotocin on the ultrastructure of rat pancreatic islets. Microsc Res Tech 2004;63:274-81.
Surwit RS, Feinglos MN, Rodin J, Sutherland A, Petro AE, Opara EC, et al. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 1995;44:645-51.
Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000;106:171-6.
Andrikopoulos S. Obesity and Type 2 diabetes: Slow down! Can metabolic deceleration protect the islet beta cell from excess nutrient-induced damage? Mol Cell Endocrinol 2010;316:140-6.
Cooper ME, Regnell SE. The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake. Br J Clin Pharmacol 2014;77:21-30.
Friedman MI. Obesity and the hepatic control of feeding behavior. Drug News Perspect 2007;20:573-8.
Panigrahi G, Panda C, Patra A. Extract of Sesbania grandiflora ameliorates hyperglycemia in high fat diet-streptozotocin induced experimental diabetes mellitus. Scientifica (Cairo) 2016;2016:4083568.
Singleton JR, Smith AG, Russell JW, Feldman EL. Microvascular complications of impaired glucose tolerance. Diabetes 2003;52:2867 73.
Robertson RP. Estimation of beta-cell mass by metabolic tests: Necessary, but how sufficient? Diabetes 2007;56:2420-4.
Patel TP, Soni S, Parikh P, Gosai J, Chruvattil R, Gupta S. Swertiamarin: An active lead from Enicostemma littorale regulates hepatic and adipose tissue gene expression by targeting PPAR- γ and improves insulin sensitivity in experimental NIDDM rat model. Evid Based Complement Alternat Med 2013;358:673.
Han BG, Hao CM, Tchekneva EE, Wang YY, Lee CA, Ebrahim B, et al. Markers of glycemic control in the mouse: Comparisons of 6-h- and overnight-fasted blood glucoses to HB A1c. Am J Physiol Endocrinol Metab 2008;295:E981-6.
Alberti KG, Press CM. The biochemistry and the complications of diabetes. In: Keen H, Jarrett J, editors. Complications of Diabetes. London: Edward Arnold; 1982. p. 231-e70.
Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A, et al. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med 1976;295:417-20.
Howlett J, Ashwell M. Glycemic response and health: Summary of a workshop. Am J Clin Nutr 2008;87:212S-216S.
König M, Bulik S, Holzhütter HG. Quantifying the contribution of the liver to glucose homeostasis: A detailed kinetic model of human hepatic glucose metabolism. PLoS Comput Biol 2012;8:e1002577.
McAnuff MA, Omoruyi FO, Morrison EY, Asemota HN. Changes in some liver enzymes in streptozotocin-induced diabetic rats fed sapogenin extract from bitter yam (Dioscorea polygonoides) or commercial diosgenin. West Indian Med J 2005;54:97-101.
Laakso M, Malkki M, Deeb SS. Amino acid substitutions in hexokinase II among patients with NIDDM. Diabetes 1995;44:330-4.
Xu Y, Osborne BW, Stanton RC. Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex. Am J Physiol Renal Physiol 2005;289:F1040-7.
Ahamad J, Hassan N, Amin S, Mir SR. Swertiamarin contributes to glucose homeostasis via inhibition of carbohydrate metabolizing enzymes. J Natl Remed 2016;16:125-30.
Erion DM, Shulman GI. Diacylglycerol-mediated insulin resistance. Nat Med 2010;16:400-2.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
